Silence Therapeutics plc

SLN·NasdaqGM
Compare
9.65−0.21 (−2.13%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close9.86
Open9.79
Day range9.5910.36
52-week range4.1917.58
Off day high−6.81%
Off 52-week high−45.10%
Volume550.99K
Avg. volume (3M)1.14M
Market cap599.79M
EPS (TTM)-1.29
Forward P/E-25.39
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding62.15M
Short interest—
Earnings dateAug 10, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
SLN BNTC ADRX WVE ZVRA LXRX
Market cap 599.79M 316.39M 1.92B 646.32M 672.22M 734.18M
P/E (TTM) — — — — 12.3 —
Forward P/E -25.4 -1.0 — -2.8 10.5 -8.7
Price/book 11.9 1.8 -0.8 1.4 3.1 4.2
Dividend yield — — — — — —
1-year change +79.27% −40.87% −7.13% −55.58% +6.55% +16.67%
Today −2.13% +2.25% +1.07% −5.20% −0.61% −1.79%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All SLN news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.